Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | 0.00% | 0.00% | +2.46% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 410M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.17M | Net income 2022 | 501M 69.2M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 839M | Net cash position 2022 | 6.66B 920M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Current month | -7.41% | ||
1 month | -16.67% | ||
Current year | +2.46% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.25 | 0.00% | 1,788 |
24-04-12 | 1.25 | -3.85% | 2,433 |
24-04-11 | 1.3 | 0.00% | 2,331 |
Delayed Quote OTC Markets, April 19, 2024 at 10:05 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+2.46% | 167M | |
-11.66% | 87.46B | |
+12.72% | 78.56B | |
+10.85% | 29.37B | |
-11.36% | 16.78B | |
-4.17% | 16.01B | |
-6.85% | 13.98B | |
+0.92% | 12.31B | |
-30.35% | 12.07B | |
+22.01% | 11.06B |
- Stock Market
- Equities
- CORB.F Stock